FDA Approves SYMBICORT(R) for Chronic Obstructive Pulmonary Disease (COPD)

... oral candidiasis, bronchitis, sinusitis and viral upper respiratory tract infection.(2) "Through ... oral candidiasis, bronchitis, sinusitis and upper respiratory tract infection. Common adverse ... of patients, included nasopharyngitis, headache, upper respiratory tract infection, pharyngolaryngeal ...

MultiVu Video Feed: U.S Food and Drug Administration (Fda) Approves Latisse(TM) --

... prescription treatment applied to the base of the upper eyelashes with a sterile, single-use-per-eye ... solution is intended for use on the skin of the upper eyelid margins at the base of the eyelashes. DO ... touches. Any excess solution outside the upper eyelid margin should be blotted with a tissue or ...

Video: Allergan Announces U.S. Food and Drug Administration (FDA) Approval of Latisse(TM) -- First and Only Treatment Approved by the FDA for Hypotrichosis of Eyelashes

... prescription treatment applied to the base of the upper eyelashes with a sterile, single-use-per-eye ... to apply either LATISSE(TM) or vehicle to both upper eyelid margins once daily for 16 weeks. The ... solution is intended for use on the skin of the upper eyelid margins at the base of the eyelashes. DO ...

Touch Bionics unveils innovative partner and reimbursement programs at AOPA

... all sizes to support patients with the latest in upper limb technology. "The Partner Program is a key ... Touch Bionics' clinical advocates, themselves upper limb amputees, in interfacing with new ... help partners to generate interest among existing upper limb patients, new patient contacts from within ...

Virgin Atlantic to Offer Zero-Emissions GM Hydrogen Fuel Cell Limousines to Upper Class Passengers

... need to play a major role." As part of the upper Class flight experience, Virgin Atlantic ... of the fleet of cars used to transport upper Class passengers to and from Los Angeles ... the Equinox Fuel Cell vehicle as part of the upper Class automotive fleet will not only reduce the ...

Ortho Biotech Modifies Prescribing Information for PROCRIT(R) (Epoetin alfa) Label Reflects Recommendations from Recent FDA Advisory Committee Meetings

... to avoid transfusions and not to exceed an upper hemoglobin safety limit of 12 grams per deciliter ... renal failure patients with anemia; a hemoglobin upper limit of 12 g/dL of blood for oncology patients ... paresthesia), rash, constipation, and upper respiratory infection. Please visit ...

New Report Just Published: World Endoscopy Systems Market Report

... II-23 Gastrointestinal II-23 Capsule Endoscopy II-24 upper Intestinal Endoscopy II-24 Colonoscopy II-24 Duodenoscopy II-24 ... Choledoscopy II-28 Esophagogastroduodenoscopy / Gastroscopy / upper Endoscopy II-28 Small Bowel Radiograph II-28 Barium Follow Through ...

Cimzia(R) (certolizumab pegol) Provides Long-Term Remission and Response Rates in Infliximab-Refractory Crohn's Patients

... CIMZIA patients (n=620) and more frequently than with placebo (n=614) were upper respiratory infection (20% CIMZIA, 13% placebo), urinary tract infection ... frequently than with placebo with concomitant methotrexate (n=324) were upper respiratory tract infection (6% CIMZIA, 2% placebo), headache (5% CIMZIA, ...

Centocor Ortho Biotech Data to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting

... hemoglobin level sufficient to avoid transfusion and not to exceed the upper safety limit of 12 g/dL. Monitor hemoglobin ... or tickling or itching or burning; paresthesia), rash, constipation and upper respiratory infection. Please visit www.procrit.com ...

Schering-Plough Announces Changes to its Global Collaboration with Novartis to Develop Combination Therapies for Asthma and COPD

... of age and older include headache, allergic rhinitis, sore throat, and upper respiratory infection. Additional important product information is ... the most common adverse events reported with FORADIL AEROLIZER were upper respiratory infection, back pain, and sore throat. In asthma clinical ...

BodyMedia, Inc. Launches GowearFit, the First Direct-to-Consumer Lifestyle and Calorie Management System

... level of accuracy, which is more than 90%. Worn comfortably on the upper left arm, GoWear® fit 's patented multi-sensor technology ... system has three components: o   An Armband, worn on the upper left arm; o   An Online Activity Manager - which allows ...

Global Study Shows That Majority of Women with Osteoporosis Do Not Consider Themselves at Higher Risk for Fractures

... namely the spine, ankle, arm, collarbone, hip, pelvis, rib, wrist, and upper and lower leg. "Currently osteoporosis remains under-diagnosed and ... sites (spine, ankle, arm, collarbone, hip, pelvis, rib, wrist, and upper and lower leg). Fracture history was correlated to a patient's ...

Touch Bionics acquires LIVINGSKIN

... Bionics CEO. "LIVINGKSIN provides the world's most advanced cosmesis for upper limb prosthetics and the i-LIMB Hand is the world's most advanced upper limb device. It's a perfect match. The acquisition of LIVINGSKIN provides ...

Data for Oncothyreon's PX-12 and PX-866 presented at AACR Annual Meeting

... levels in all patients with initial levels greater than 18 ng/mL, the upper limit of the normal range. Patients with normal Trx-1 levels remained ... these data suggest that patients with plasma Trx-1 levels above the normal upper limit of 18 ng/mL may be more likely to benefit from treatment with PX-12. ...

Cardium's InnerCool Therapies Unit Announces European Commercialization Agreement for Portfolio of Temperature Modulation Systems

... system, which includes a console and a disposable CoolBlue vest with upper thigh pads, is designed to provide a tool for use in less acute patients ... system, which includes a console and a disposable CoolBlue(TM) vest with upper thigh pads, is designed to provide a complementary tool for use in less ...

MIT explains spread of 1918 flu

... (HA), which allowed it to bind tightly to receptors in the human upper respiratory tract. Two mutations dramatically change the HA binding affinity to receptors found in the human upper airways, said Ram Sasisekharan, the Underwood Prescott Professor of ...

Touch Bionics adds to sales, marketing, production and design teams

... in booth 1117. A workshop presented by Touch Bionics entitled "Bionic upper Limb Technology Made Easy," workshop Number 32, will take place on ... to offer bionic technology from their practices and transform the lives of upper limb patients. For more information, please visit ...

Touch Bionics expands U.S. presence to meet demand for i-LIMB Hand

... in booth 1117. A workshop presented by Touch Bionics entitled "Bionic upper Limb Technology Made Easy," workshop Number 32, will take place on ... to offer bionic technology from their practices and transform the lives of upper limb patients. For more information, please visit ...

Cephalon Submits Supplemental New Drug Application for FENTORA

... dissolves and how quickly the medicine passes across the lining of the upper check, or buccal mucosa. With FENTORA's drug delivery technology, approximately half of the medicine is absorbed directly across the lining of the upper cheek and into the bloodstream. Conventional short-acting oral opioids, ...

Creating the Bionic Woman: Making Nerves Spring Back to Life

... and move their prostheses. Often, there is little muscle left following an upper arm amputation, making it difficult to maneuver the artificial limb. Surgeons are transferring the remaining nerves in the upper arm to chest and back muscles, allowing those muscles to help control and ...

Endo Pharmaceuticals Reports Strong Second Quarter 2009 Financial Results

... billion. Adjusted diluted earnings per share are projected to be between $2.59 and $2.67. The company now believes that it is likely to achieve the upper end of the adjusted diluted earnings per share guidance range. We now forecast reported (GAAP) diluted earnings per share to be between $1.26 and ....

Elagolix Successful in Six Month Lilac Petal Study; Safety and Efficacy Confirmed in Patients With Endometriosis

... O'Brien, Chief Medical Officer of Neurocrine Biosciences, "Most importantly, we find that the 250 mg once-daily dose, chosen to inform us about the upper limit of dosing, met the pre-defined threshold for bone impact." From an efficacy standpoint, the exploratory daily pain scales for ...

NewBridge Pharmaceuticals Announces Licensing of Pylera(R) for Middle East, Africa, Turkey & Caspian Region

... the Helicobacter pylori organism was one of the major advances in gastroenterology in recent decades, as it has revolutionized the approach to many upper gastrointestinal disorders. Helicobacter pylori is believed to cause a spectrum of diseases in humans, including gastritis, ulcer disease (gastric ...

Study Published in Child and Adolescent Psychiatry and Mental Health Demonstrated Once-Daily Vyvanse(R) (lisdexamfetamine dimesylate) CII Provided Significant Improvement of ADHD Symptoms for Children at 13 Hours After Administration

... than or equal to 10 percent) in the dose-optimization phase for patients taking Vyvanse were decreased appetite, insomnia, headache, irritability, upper abdominal pain, and affect lability. Vyvanse, which was introduced in the United States in July 2007 for the treatment of ADHD in children ...

NeoStem Featured on CBS2 News; Success of Licensed Stem Cell Treatments Shown for Arthritis and Orthopedic Problems; Procedure to be Used by NeoStem Affiliate in China

... in collaboration with experts in the PRC for each clinical indication to be pursued. China has a large population with a rapidly growing middle and upper class who are becoming focused on regenerative medicine and can afford such services. We believe that a collaboration involving these two countries ...

DermTech and Stiefel Laboratories, Inc. to Further Evaluate EGIR(TM) Technology

... development is a non-invasive test to detect the presence of melanoma. The EGIR technology uses custom adhesive tape to easily obtain RNA from the upper layer of skin overlying a suspicious lesion. A proprietary 19-gene biomarker is then used to analyze the genetic material to differentiate ...

DOR BioPharma Announces Issuance of European Patent for its LPM(TM) Oral Drug Delivery Technology

... extremely large molecules, bacteria and viruses. The reverse micelles also structurally prevent the rapid inactivation of peptides by enzymes in the upper gastrointestinal tract. Other sensitive drugs that can be delivered orally with the LPM(TM) system include various classes of drugs such as peptides, ...

Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment

... events (greater than or equal to 5 percent) for patients during the dose-optimization phase were decreased appetite, dry mouth, headache, insomnia, upper respiratory tract infection, irritability, nausea, anxiety, and feeling jittery. VYVANSE, which was introduced in the United States in July ...

Horizon Therapeutics Names Dr. Jeffrey W. Sherman Executive Vice President and Chief Medical Officer

... ibuprofen, with a high dose of the most potent H2 antagonist, famotidine. HZT-501 was shown to significantly reduce the incidence of NSAID-induced upper gastrointestinal ulcers in patients with mild-to-moderate pain in two Phase 3 studies. Dr. Sherman joins Horizon from IDM Pharma, which was ...

MEDS World, LLC Provides Multiple Environments with Designed Solutions - Wherever People Congregate, MEDS Odor Elimination Solutions Offer Eco-Friendly, Odor-Free Air

... of our active-oxidant, known to eliminate hazardous and toxic bacteria. In a locker room study of a major University, MEDS products reduced upper respiratory infections by twenty-five percent. The active-oxidant in MEDS is similar to the anti-microbial used to eliminate Anthrax spores in the ...

Sanofi Pasteur Responds to Nation's Need for Hib Vaccine With Increased Supply

... which remains constrained in the short term. About Hib Disease Haemophilus influenzae type b, or Hib, is a bacterium that resides in the upper respiratory tract of humans and is usually transmitted by coughing or sneezing. Invasive Hib disease can be very severe, and can cause ...

ViroPharma Receives Complete Response Letter for Cinryze(TM) Supplemental Biologics License Application for Acute Treatment of Hereditary Angioedema

... to treat patients with C1 inhibitor deficiency. Cinryze has been generally well tolerated. The most common adverse reactions observed have been upper respiratory infection, sinusitis, rash and headache. No drug-related serious adverse events (SAEs) have been observed in clinical trials. Severe ...

Nature parks can save species as climate changes

... forest to provide corridors for the movement of wildlife between them. It protects one of the largest remaining blocks of intact forest in the upper Guinea Area of West Africa. ...

FDA Approves Labeling Change for VYVANSE(R) (lisdexamfetamine dimesylate) CII to Include Supplementary Clinical Data Supporting Efficacy at 13 Hours Postdose in Children Aged 6 to 12 with ADHD

... 10 percent and twice placebo) in the dose optimization phase for patients taking VYVANSE were decreased appetite, insomnia, headache, irritability, upper abdominal pain, and affect lability (mood swings). VYVANSE, which was introduced in the United States in July 2007 for the treatment of ADHD in ...

AGA Institute and Horizon Therapeutics Launch 'Connect to Protect' Program to Educate Physicians and Consumers on Risks Associated With NSAID Use

... About NSAIDs and GI Toxicity It is estimated that more than 60 million Americans use NSAIDs regularly, resulting in clinically significant upper GI events in one to two percent of users. NSAIDs, most often used for the treatment of arthritis and pain, block enzymes and reduce prostaglandins ...

China Sky One Medical, Inc. Obtains Production Approval for Two New Drugs

... virus. Shuanghuanglian suppositories helps relieve cold and flu symptoms such as fever, cough and sore throat pain. It can also be used to treat upper respiratory infections and pneumonia. Both of the products are for common diseases, and should benefit as a result of the rapidly expanded rural ...

Smith & Nephew Endoscopy Launches the BICEPTOR(TM) Tenodesis System, the First All-Arthroscopic Procedure for Biceps Tendon Repair

... Smith & Nephew Endoscopy's BICEPTOR Tenodesis System is the first that enables surgeons to re-attach the biceps tendon to the humerus, or upper arm bone, using an all-arthroscopic technique. Other biceps tenodesis techniques require the extra step of withdrawing the damaged end of the biceps ...

ViroPharma Incorporated Honored by the National Organization for Rare Disorders

... treat patients with C1 inhibitor deficiency. Cinryze has been generally well tolerated. The most common adverse reactions observed have been upper respiratory infection, sinusitis, rash and headache. No drug-related serious adverse events (SAEs) have been observed in clinical trials. Severe ...

Pierre Fabre Dermatologie Starts Clinical Trials on a Beta-Blocker to Treat Severe Infantile Haemangioma

... to as a "strawberry mark". Local complications may occur in the form of ulceration and critical localisations such as the eye area or the upper respiratory tract. These complications are the serious forms of the disease and represent 10% of total haemangioma occurrence, or 1% of births. First ...

Evoke Pharma, Inc. Initiates Phase 2b Metoclopramide Intranasal Trial (MINT) in Patients With Diabetic Gastroparesis

... gastroparesis may experience symptoms of: postprandial fullness, nausea, vomiting, particularly vomiting of food ingested several hours previously, upper abdominal distention (bloating), early satiety, and anorexia. Severe symptoms may result in poor nutrition and dehydration resulting in ...